生存率-话题@MedSci

#生存率#

482篇内容 | 3068人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256665, encodeId=301b125666561, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？, objectType=article, longId=144329, objectId=fcb514432948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcb514432948, replyNumber=0, likeNumber=59, createdTime=2018-07-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcb514432948, moduleTitle=J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcb514432948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256664, encodeId=65151256664f4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Hepatol：长期恩替卡韦/替诺福韦治疗CHB 生存率影响几何？, objectType=article, longId=141768, objectId=a500141e68d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a500141e68d7, replyNumber=0, likeNumber=73, createdTime=2018-06-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a500141e68d7, moduleTitle=J Hepatol：长期恩替卡韦/替诺福韦治疗CHB 生存率影响几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a500141e68d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256663, encodeId=2e9d12566632e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素, objectType=article, longId=141443, objectId=c0ee14144387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0ee14144387, replyNumber=0, likeNumber=63, createdTime=2018-06-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0ee14144387, moduleTitle=J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0ee14144387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256662, encodeId=c4fa125666218, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Circ: Cardiovascular Interventions：手术高危二尖瓣返流患者二尖瓣夹合术后的生存率, objectType=article, longId=140933, objectId=a50d140933ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a50d140933ae, replyNumber=0, likeNumber=77, createdTime=2018-06-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a50d140933ae, moduleTitle=Circ: Cardiovascular Interventions：手术高危二尖瓣返流患者二尖瓣夹合术后的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a50d140933ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256661, encodeId=7d80125666187, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=赫捷院士：中国恶性肿瘤5年生存率已提升至40.5%, objectType=article, longId=140453, objectId=26c014045397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26c014045397, replyNumber=0, likeNumber=55, createdTime=2018-06-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26c014045397, moduleTitle=赫捷院士：中国恶性肿瘤5年生存率已提升至40.5%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26c014045397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256660, encodeId=95a11256660b1, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率, objectType=article, longId=140424, objectId=6c87140424b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c87140424b8, replyNumber=0, likeNumber=64, createdTime=2018-06-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c87140424b8, moduleTitle=Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c87140424b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256659, encodeId=ecf11256659f5, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率, objectType=article, longId=139713, objectId=53d8139e13a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53d8139e13a9, replyNumber=0, likeNumber=75, createdTime=2018-06-03, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53d8139e13a9, moduleTitle=Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53d8139e13a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256658, encodeId=07831256658fe, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率, objectType=article, longId=139692, objectId=7abe13969219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7abe13969219, replyNumber=0, likeNumber=76, createdTime=2018-06-03, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7abe13969219, moduleTitle=Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7abe13969219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256657, encodeId=4ab5125665e93, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=未来科学大奖得主卢煜明:利用DNA检测提高病人生存率, objectType=article, longId=139500, objectId=5097139500d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5097139500d1, replyNumber=0, likeNumber=76, createdTime=2018-06-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5097139500d1, moduleTitle=未来科学大奖得主卢煜明:利用DNA检测提高病人生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5097139500d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256656, encodeId=94e11256656ca, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Ann Rheum Dis：肉芽肿病伴多血管炎引起的终末期肾病患者肾移植后的生存率改善, objectType=article, longId=138223, objectId=bc4a138223ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc4a138223ec, replyNumber=0, likeNumber=67, createdTime=2018-05-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc4a138223ec, moduleTitle=Ann Rheum Dis：肉芽肿病伴多血管炎引起的终末期肾病患者肾移植后的生存率改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc4a138223ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256655, encodeId=ac0e125665595, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Liver Int：与病毒性HCC患者相比，隐型肝癌患者的肿瘤更大，肿瘤分期愈晚，总体生存率较低, objectType=article, longId=138154, objectId=208313815466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=208313815466, replyNumber=0, likeNumber=60, createdTime=2018-05-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=208313815466, moduleTitle=Liver Int：与病毒性HCC患者相比，隐型肝癌患者的肿瘤更大，肿瘤分期愈晚，总体生存率较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=208313815466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256654, encodeId=7e53125665480, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=PLos One：S100A16异常表达可作为非小细胞肺腺癌不良生存率的独立预后指标, objectType=article, longId=138049, objectId=e64e13804901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e64e13804901, replyNumber=0, likeNumber=15, createdTime=2018-05-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e64e13804901, moduleTitle=PLos One：S100A16异常表达可作为非小细胞肺腺癌不良生存率的独立预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e64e13804901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256653, encodeId=01d81256653f7, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Oncol：改善癌症患者生存率健康保险功不可没, objectType=article, longId=137820, objectId=413b13e82037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=413b13e82037, replyNumber=0, likeNumber=41, createdTime=2018-05-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=413b13e82037, moduleTitle=JAMA Oncol：改善癌症患者生存率健康保险功不可没, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=413b13e82037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256652, encodeId=04d81256652a4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=严重心衰5年生存率比癌症更低，专家呼吁加强认识和综合治疗, objectType=article, longId=137435, objectId=da3513e4356e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da3513e4356e, replyNumber=0, likeNumber=67, createdTime=2018-05-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da3513e4356e, moduleTitle=严重心衰5年生存率比癌症更低，专家呼吁加强认识和综合治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da3513e4356e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256651, encodeId=288a12566514b, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Oncology:长达7年随访表明，遵守ACS营养和运动指南，能使中期肠癌患者术后5年生存率提高9%, objectType=article, longId=136730, objectId=d1c4136e3053, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1c4136e3053, replyNumber=0, likeNumber=58, createdTime=2018-04-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1c4136e3053, moduleTitle=JAMA Oncology:长达7年随访表明，遵守ACS营养和运动指南，能使中期肠癌患者术后5年生存率提高9%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1c4136e3053)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256650, encodeId=ce691256650ab, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=PLOS ONE：如何预测无尿腹膜透析患者生存率, objectType=article, longId=136642, objectId=a99413664273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a99413664273, replyNumber=0, likeNumber=65, createdTime=2018-04-28, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a99413664273, moduleTitle=PLOS ONE：如何预测无尿腹膜透析患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a99413664273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256649, encodeId=c5bf1256649d8, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet Glob Health：癌症生存率显著上升！《柳叶刀》公布12年中国癌症大数据分析！, objectType=article, longId=135887, objectId=485313588e2b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=485313588e2b, replyNumber=0, likeNumber=69, createdTime=2018-04-21, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=485313588e2b, moduleTitle=Lancet Glob Health：癌症生存率显著上升！《柳叶刀》公布12年中国癌症大数据分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=485313588e2b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256648, encodeId=65ae125664831, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=NEJM：Keytruda辅助治疗可显著提高III期黑色素瘤患者生存率, objectType=article, longId=135501, objectId=edf51355017d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edf51355017d, replyNumber=0, likeNumber=51, createdTime=2018-04-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edf51355017d, moduleTitle=NEJM：Keytruda辅助治疗可显著提高III期黑色素瘤患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edf51355017d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256647, encodeId=48da125664ea4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Rheumatol：系统性硬化症中的静脉血栓栓塞：患病率、危险因素和对生存率的影响, objectType=article, longId=135466, objectId=46ac1354664a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46ac1354664a, replyNumber=0, likeNumber=87, createdTime=2018-04-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46ac1354664a, moduleTitle=J Rheumatol：系统性硬化症中的静脉血栓栓塞：患病率、危险因素和对生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46ac1354664a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256646, encodeId=4608125664673, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Radiology：肾癌患者的世纪福音！减少腹部脂肪或可提高生存率！, objectType=article, longId=134693, objectId=d993134693e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d993134693e9, replyNumber=0, likeNumber=0, createdTime=2018-04-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d993134693e9, moduleTitle=Radiology：肾癌患者的世纪福音！减少腹部脂肪或可提高生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d993134693e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Natl Cancer Inst：诺模图能预测晚期结直肠癌的生存率？

2018-07-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Hepatol：长期恩替卡韦/替诺福韦治疗CHB 生存率影响几何？

2018-06-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素

2018-06-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Circ: Cardiovascular Interventions：手术高危二尖瓣返流患者二尖瓣夹合术后的生存率

2018-06-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

赫捷院士：中国恶性肿瘤5年生存率已提升至40.5%

2018-06-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Aliment Pharmacol Ther：抗病毒治疗可提高乙肝病毒相关肝细胞癌患者的生存率

2018-06-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率

2018-06-03

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Journal of Clinical Gastroenterology：溃疡性结肠炎患者结肠巨细胞病毒感染的抗病毒治疗显着提高了其手术无生存率

2018-06-03

guoyibin (审核中...)

前往app查看评论内容

#生存率#

未来科学大奖得主卢煜明:利用DNA检测提高病人生存率

2018-06-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Ann Rheum Dis：肉芽肿病伴多血管炎引起的终末期肾病患者肾移植后的生存率改善

2018-05-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Liver Int：与病毒性HCC患者相比，隐型肝癌患者的肿瘤更大，肿瘤分期愈晚，总体生存率较低

2018-05-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

PLos One：S100A16异常表达可作为非小细胞肺腺癌不良生存率的独立预后指标

2018-05-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Oncol：改善癌症患者生存率健康保险功不可没

2018-05-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

严重心衰5年生存率比癌症更低，专家呼吁加强认识和综合治疗

2018-05-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Oncology:长达7年随访表明，遵守ACS营养和运动指南，能使中期肠癌患者术后5年生存率提高9%

2018-04-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

PLOS ONE：如何预测无尿腹膜透析患者生存率

2018-04-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet Glob Health：癌症生存率显著上升！《柳叶刀》公布12年中国癌症大数据分析！

2018-04-21

guoyibin (审核中...)

前往app查看评论内容

#生存率#

NEJM：Keytruda辅助治疗可显著提高III期黑色素瘤患者生存率

2018-04-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Rheumatol：系统性硬化症中的静脉血栓栓塞：患病率、危险因素和对生存率的影响

2018-04-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Radiology：肾癌患者的世纪福音！减少腹部脂肪或可提高生存率！

2018-04-11

科室
- - 订阅+
  - 更多科室
工具
服务